Tianjin Tianyao Pharmaceuticals Co Ltd (600488) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥13.19 Million ≈ $1.93 Million USD) by net assets (CN¥3.89 Billion ≈ $569.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tianjin Tianyao Pharmaceuticals Co Ltd - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Tianjin Tianyao Pharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Tianjin Tianyao Pharmaceuticals Co Ltd (600488) financial obligations for a breakdown of total debt and financial obligations.

Tianjin Tianyao Pharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Tianyao Pharmaceuticals Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ategrity Specialty Insurance Company Holdings NYSE:ASIC	0.256x
Arena REIT AU:ARF	0.029x
Thungela Resources Limited JSE:TGA	0.082x
Bumi Serpong Damai Tbk JK:BSDE	-0.009x
Yuhuan CNC Machine Tool Co Ltd SHE:002903	0.005x
Bear Electric Appliance Co Ltd SHE:002959	-0.001x
Daewon Cable KO:006340	-0.036x
China Motor Corp TW:2204	0.028x

Annual Cash Flow Conversion Efficiency for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)

The table below shows the annual cash flow conversion efficiency of Tianjin Tianyao Pharmaceuticals Co Ltd from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see 600488 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.89 Billion ≈ $568.62 Million	CN¥569.37 Million ≈ $83.32 Million	0.147x	-29.76%
2023-12-31	CN¥3.75 Billion ≈ $549.23 Million	CN¥783.01 Million ≈ $114.58 Million	0.209x	+19.83%
2022-12-31	CN¥3.75 Billion ≈ $549.30 Million	CN¥653.52 Million ≈ $95.63 Million	0.174x	+109.69%
2021-12-31	CN¥3.82 Billion ≈ $558.53 Million	CN¥316.89 Million ≈ $46.37 Million	0.083x	-9.71%
2020-12-31	CN¥3.77 Billion ≈ $552.05 Million	CN¥346.88 Million ≈ $50.76 Million	0.092x	+18.02%
2019-12-31	CN¥3.59 Billion ≈ $524.74 Million	CN¥279.37 Million ≈ $40.88 Million	0.078x	+35.10%
2018-12-31	CN¥3.28 Billion ≈ $480.28 Million	CN¥189.27 Million ≈ $27.70 Million	0.058x	+2315.44%
2017-12-31	CN¥3.13 Billion ≈ $457.91 Million	CN¥-8.15 Million ≈ $-1.19 Million	-0.003x	-110.24%
2016-12-31	CN¥2.49 Billion ≈ $364.44 Million	CN¥63.32 Million ≈ $9.27 Million	0.025x	-51.92%
2015-12-31	CN¥2.45 Billion ≈ $358.33 Million	CN¥129.50 Million ≈ $18.95 Million	0.053x	-29.13%
2014-12-31	CN¥2.40 Billion ≈ $350.53 Million	CN¥178.76 Million ≈ $26.16 Million	0.075x	+105.28%
2013-12-31	CN¥2.33 Billion ≈ $340.36 Million	CN¥84.55 Million ≈ $12.37 Million	0.036x	+385.84%
2012-12-31	CN¥1.77 Billion ≈ $258.69 Million	CN¥13.23 Million ≈ $1.94 Million	0.007x	-83.92%
2011-12-31	CN¥1.69 Billion ≈ $246.84 Million	CN¥78.47 Million ≈ $11.48 Million	0.047x	-35.03%
2010-12-31	CN¥1.63 Billion ≈ $238.75 Million	CN¥116.82 Million ≈ $17.09 Million	0.072x	-74.40%
2009-12-31	CN¥1.56 Billion ≈ $227.69 Million	CN¥435.13 Million ≈ $63.67 Million	0.280x	+91.77%
2008-12-31	CN¥1.50 Billion ≈ $220.07 Million	CN¥219.31 Million ≈ $32.09 Million	0.146x	+31.22%
2007-12-31	CN¥1.46 Billion ≈ $213.75 Million	CN¥162.33 Million ≈ $23.75 Million	0.111x	+136.07%
2006-12-31	CN¥1.08 Billion ≈ $157.67 Million	CN¥50.72 Million ≈ $7.42 Million	0.047x	+145.17%
2005-12-31	CN¥1.04 Billion ≈ $152.86 Million	CN¥-108.87 Million ≈ $-15.93 Million	-0.104x	-193.30%
2004-12-31	CN¥987.47 Million ≈ $144.50 Million	CN¥110.30 Million ≈ $16.14 Million	0.112x	+128.34%
2003-12-31	CN¥935.65 Million ≈ $136.92 Million	CN¥45.77 Million ≈ $6.70 Million	0.049x	-15.24%
2002-12-31	CN¥784.51 Million ≈ $114.80 Million	CN¥45.28 Million ≈ $6.63 Million	0.058x	-42.62%
2001-12-31	CN¥714.63 Million ≈ $104.57 Million	CN¥71.87 Million ≈ $10.52 Million	0.101x	-48.14%
2000-12-31	CN¥211.75 Million ≈ $30.99 Million	CN¥41.06 Million ≈ $6.01 Million	0.194x	--

About Tianjin Tianyao Pharmaceuticals Co Ltd

SHG:600488 China Drug Manufacturers - Specialty & Generic

Market Cap

$942.69 Million

CN¥6.44 Billion CNY

Market Cap Rank

#9425 Global

#2587 in China

Share Price

CN¥5.90

Change (1 day)

+3.51%

52-Week Range

CN¥3.71 - CN¥7.67

All Time High

CN¥7.67